Neuberger Berman Group LLC Bristol Myers Squibb CO Transaction History
Neuberger Berman Group LLC
- $130 Billion
- Q3 2025
A detailed history of Neuberger Berman Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Neuberger Berman Group LLC holds 861,178 shares of BMY stock, worth $40.3 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
861,178
Previous 3,161,052
72.76%
Holding current value
$40.3 Million
Previous $146 Million
73.46%
% of portfolio
0.03%
Previous 0.12%
Shares
36 transactions
Others Institutions Holding BMY
# of Institutions
2,692Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...